...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >MiR-195 inhibits proliferation and growth and induces apoptosis of endometrial stromal cells by targeting FKN
【24h】

MiR-195 inhibits proliferation and growth and induces apoptosis of endometrial stromal cells by targeting FKN

机译:MiR-195通过靶向FKN抑制子宫内膜基质细胞的增殖和生长并诱导其凋亡

获取原文

摘要

MiR-195, which exhibits a proliferation-inhibiting role in different tumors, has been reported to be down-regulated in the ectopic endometrium. The aim of this study was to determine the impact of miR-195 on the biological characteristic of the endometrial stromal cells (ESCs). MiR-195 has been presumed to target the 3’-untranslated regions (3’-UTR) of Fractalkine (FKN), which also plays important roles in endometriosis. Fluorescence reporter assays showed that miR-195 effectively binds to the 3’-UTR of FKN. The normal ESCs showed a significant higher miR-195 expression than that of eutopic and ectopic ESCs associated with endometriosis, while the FKN expression showed opposite results. MiR-195 mimics inhibited proliferation and growth and induced apoptosis of eutopic ESCs, and these effects were abolished by FKN-siRNA. miR-195 could decrease the expression of survivin, matrix metalloproteinase-9 (MMP9) and up-regulate the expression of CD82, tissue inhibitor of metalloproteinase 1 (TIMP1) and TIMP2 of eutopic ESCs by targeting FKN. Our study has demonstrated for the first time that miR-195 plays important roles in regulating the functions of ESCs through targeting FKN. The information may be useful for developing a new therapeutic strategy for endometriosis.
机译:据报道,在不同肿瘤中具有抑制增殖作用的MiR-195在异位子宫内膜中被下调。这项研究的目的是确定miR-195对子宫内膜基质细胞(ESCs)生物学特性的影响。据推测,MiR-195靶向Fractalkine(FKN)的3'非翻译区(3'-UTR),在子宫内膜异位症中也起着重要作用。荧光报告基因分析表明,miR-195与FKN的3'-UTR有效结合。正常ESCs显示与子宫内膜异位症相关的异位和异位ESCs的miR-195表达显着较高,而FKN表达显示相反的结果。 MiR-195模拟物抑制异位ESC的增殖和生长并诱导其凋亡,FKN-siRNA消除了这些作用。 miR-195可通过靶向FKN来降低survivin,基质金属蛋白酶9(MMP9)的表达并上调CD82,金属蛋白酶1组织抑制剂(TIMP1)和TIMP2的表达。我们的研究首次证明miR-195通过靶向FKN在调节ESC的功能中起重要作用。该信息对于开发子宫内膜异位症的新治疗策略可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号